India to Russia: Docetaxel Export Trade Route

The India to Russia Docetaxel corridor is one of India's established pharmaceutical export routes, with 18 shipments documented worth a combined $2.7M USD. The route is dominated by JODAS EXPOIM PRIVATE LIMITED, which alone accounts for roughly 75% of all export value, reflecting the consolidated nature of India's docetaxel manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $147.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with docetaxel's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 19.0%, placing it at rank #18 among India's top docetaxel export destinations globally.

On the import side, key buyers of Indian docetaxel in Russia include OOOJODAS EXPOIM, OOO"JODAS EXPOIM" , OOO"JODAS EXPOIM" and 3 others. OOOJODAS EXPOIM is the single largest importer with 6 shipments valued at $998.7K USD.

India's docetaxel exports to Russia are driven primarily by a handful of large-scale manufacturers. JODAS EXPOIM PRIVATE LIMITED with 12 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Russia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — JODAS EXPOIM PRIVATE LIMITED, JODAS EXPOIM PRIVATE LIMITED , RUS MED EXPORTS PVT. LTD. — together account for 100% of total trade value on this route. The average shipment value of $147.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as docetaxel concentrate for solution for infusion 20mg/ml (160mg/8.0 ml)/vial #1 (as per invoice) and docetaxel concentrate for solution for infusion 20mg/ml (80mg/4.0 ml)/vial #1 (as per invoice), suggesting that buyers in Russia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, OOOJODAS EXPOIM is the largest importer with 6 shipments worth $998.7K USD — representing 38% of all docetaxel imports from India on this route. A total of 6 buyers are active on this corridor.